Centene Corporation $CNC Shares Purchased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lifted its holdings in Centene Corporation (NYSE:CNC) by 378.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 353,911 shares of the company’s stock after buying an additional 279,952 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.07% of Centene worth $13,597,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the business. Farther Finance Advisors LLC grew its holdings in shares of Centene by 5.1% in the second quarter. Farther Finance Advisors LLC now owns 6,658 shares of the company’s stock valued at $361,000 after purchasing an additional 325 shares during the period. Versant Capital Management Inc grew its stake in shares of Centene by 11.6% in the 3rd quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after buying an additional 355 shares during the period. Snowden Capital Advisors LLC increased its holdings in shares of Centene by 8.0% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock worth $275,000 after buying an additional 374 shares during the last quarter. Financial Network Wealth Advisors LLC raised its position in shares of Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after buying an additional 390 shares during the period. Finally, Geneos Wealth Management Inc. lifted its holdings in Centene by 29.8% in the second quarter. Geneos Wealth Management Inc. now owns 1,897 shares of the company’s stock valued at $103,000 after acquiring an additional 435 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Trading Up 0.2%

CNC opened at $45.33 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08. Centene Corporation has a one year low of $25.08 and a one year high of $66.81. The business’s 50-day simple moving average is $40.96 and its 200-day simple moving average is $34.99. The company has a market cap of $22.28 billion, a P/E ratio of -4.19, a PEG ratio of 1.03 and a beta of 0.48.

Centene (NYSE:CNC) last posted its earnings results on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The firm had revenue of $49.69 billion for the quarter, compared to the consensus estimate of $47.50 billion. During the same period last year, the firm posted $1.62 EPS. The company’s revenue was up 18.2% on a year-over-year basis. As a group, equities research analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CNC. UBS Group set a $42.00 price target on Centene and gave the company a “neutral” rating in a research note on Thursday, October 30th. Morgan Stanley increased their target price on shares of Centene from $28.00 to $38.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 14th. Jefferies Financial Group boosted their price target on shares of Centene from $25.00 to $32.00 in a research note on Monday, November 3rd. TD Cowen reaffirmed a “hold” rating on shares of Centene in a research report on Friday, October 31st. Finally, Robert W. Baird boosted their target price on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $40.81.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.